GLYNN WILSON
CIK 1405625 · Chief Executive Officer · last filed 2026-03-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.02M
Companies
5
Total Filings
24
Lifetime Open-Market Net
-$139.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CABR | Chief Executive Officer | 672,592 | $1.51 | $1.02M | $0 | 2 | 2026-03-27 |
| CVKD | Director | 3,333 | $2.01 | $6.7K | $0 | 3 | 2025-01-24 |
| BONK, INC. (SHOTW) Delisted | Former CSO, Chairman | — | $0.04 | — | $0 | 1 | 2024-03-06 |
| BONK, INC. (JUPWW) Delisted | CSO, Chairman | 950,000 | $0.32 | $304.0K | -$139.5K | 9 | 2022-12-30 |
| Marker Therapeutics, Inc. (TPIV) Delisted | Chief Executive Officer | 181,776 | — | — | $0 | 4 | 2018-10-10 |
Recent Filings · Page 2 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-15 | BONK, INC. (JUPWW) Delisted | Grant (A) | +200,000 | $0 | EDGAR |
| 2021-08-18 | BONK, INC. (JUPWW) Delisted | Grant (A) | +14,124 | $0 | EDGAR |
| 2021-07-27 | BONK, INC. (JUPWW) Delisted | Sell (S) | −50,000 | -$139.5K | EDGAR |
| 2021-07-02 | BONK, INC. (JUPWW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-31 | BONK, INC. (JUPWW) Delisted | Conv (C) | +200,000 | $50.0K | EDGAR |
| 2018-10-10 | Marker Therapeutics, Inc. (TPIV) Delisted | Mixed | +23,559 | $0 | EDGAR |
| 2018-09-25 | Marker Therapeutics, Inc. (TPIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-26 | Marker Therapeutics, Inc. (TPIV) Delisted | Mixed | +72,650 | $231.0K | EDGAR |
| 2017-03-13 | Marker Therapeutics, Inc. (TPIV) Delisted | Grant (A) | +12,761 | $0 | EDGAR |
| 2015-11-16 | — | Mixed | +401,782 | $243.1K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.